Articles

Phenotypic and functional characterization of the CD6-ALCAM T cell costimulatory pathway after allogeneic cell transplantation

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Ph.D. Program in Translational and Molecular Medicine (DIMET), University of Milano-Bicocca, Monza
Department of Data Science, Dana-Farber Cancer Institute, Harvard T H Chan School of Public Health, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Medical Oncology, Sapporo Medical University
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Hematology and Oncology, Himeji Red Cross Hospital, Hyogo
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Equillium, La Jolla, CA
Equillium, La Jolla, CA
Equillium, La Jolla, CA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
Haematologica Early view Apr 28, 2022 https://doi.org/10.3324/haematol.2021.280444